When foci with accumulated photosensitizer (PS) are exposed to light, photochemical reactions occur in the tissues, which end-product is reactive oxygen species (ROS). These molecules in their low concentration perform regulatory functions, whereas they are highly toxic when the concentration is high, thereby causing damage to pathological cells at the irradiated site.
The PDT REVIXAN technology implies topical application of a PS made on the base of natural molecule derivatives like chlorophyll. The advantages of such PS are its non-toxicity and absence of systemic effects.
When the skin is irradiated by light after being exposed to the REVIXAN-DERMA photosensitizing gel, the generated ROS perform their signaling functions for healthy cells, thereby stimulating their proliferative and synthetic activity, thereby optimally intensifying the physiological regeneration processes in living tissues (particularly, when PDT is combined with invasive treatment modalities).